TWiV 793: COVID-19 clinical update with Dr. Daniel Griffin
Aug 14, 2021•41 min•Ep. 793
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In COVID-19 clinical update #75, Daniel Griffin reviews vaccine effectiveness against transmission, modeling effectiveness of daily antigen tests, updated CDC guidance for fully vaccinated, risk of infection with time after mRNA vaccination, reduced risk of infection after vaccination, therapeutic anticoagulants in critically ill patients, and 6 month outcomes in hospitalized patients.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Vaccine effectiveness against transmission (Euro Surveill)
- Effectiveness of daily antigen tests (medRxiv)
- Interim guidance for fully vaccinated people (CDC)
- Elapsed time since BNT162b2 vaccine and reinfection (medRxiv)
- Reduced risk of infection after vaccination (MMWR)
- Therapeutic anticoagulants in critically ill patients (NEJM)
- 6 month outcomes in hospitalized patients (J Gen Int Med)
- Letters read on TWiV 793
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
For the best experience, listen in Metacast app for iOS or Android